Marion Friedl

15.1k total citations
21 papers, 514 citations indexed

About

Marion Friedl is a scholar working on Biological Psychiatry, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Marion Friedl has authored 21 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biological Psychiatry, 6 papers in Epidemiology and 6 papers in Psychiatry and Mental health. Recurrent topics in Marion Friedl's work include Tryptophan and brain disorders (8 papers), Toxoplasma gondii Research Studies (6 papers) and Bipolar Disorder and Treatment (5 papers). Marion Friedl is often cited by papers focused on Tryptophan and brain disorders (8 papers), Toxoplasma gondii Research Studies (6 papers) and Bipolar Disorder and Treatment (5 papers). Marion Friedl collaborates with scholars based in Germany, United States and Austria. Marion Friedl's co-authors include Annette M. Hartmann, Dan Rujescu, Bettina Konte, Ina Giegling, Teodor T. Postolache, Maureen Groër, Patricia Langenberg, Olaoluwa Okusaga, Alessandro Serretti and Robert H. Yolken and has published in prestigious journals such as PLoS ONE, Psychosomatic Medicine and Psychiatry Research.

In The Last Decade

Marion Friedl

21 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion Friedl Germany 13 195 147 132 115 91 21 514
Bettina Konte Germany 15 197 1.0× 155 1.1× 135 1.0× 173 1.5× 102 1.1× 32 646
Greg C. Bristow United Kingdom 10 263 1.3× 168 1.1× 42 0.3× 85 0.7× 39 0.4× 17 522
Jean‐Romain Richard France 14 119 0.6× 121 0.8× 177 1.3× 72 0.6× 229 2.5× 27 599
Arjen L. Sutterland Netherlands 15 307 1.6× 276 1.9× 289 2.2× 112 1.0× 341 3.7× 32 1.1k
Bogdana Krivogorsky United States 11 106 0.5× 205 1.4× 227 1.7× 147 1.3× 122 1.3× 14 662
Johannes Schröeder Germany 11 102 0.5× 114 0.8× 81 0.6× 61 0.5× 182 2.0× 21 715
Manana Lapidus United States 10 159 0.8× 102 0.7× 290 2.2× 63 0.5× 118 1.3× 13 646
Norbert Mueller Germany 13 56 0.3× 61 0.4× 221 1.7× 78 0.7× 90 1.0× 15 680
Merja Viikki Finland 20 31 0.2× 216 1.5× 211 1.6× 143 1.2× 300 3.3× 45 1.1k
Crystal Vaughan United States 17 57 0.3× 214 1.5× 501 3.8× 283 2.5× 366 4.0× 21 1.2k

Countries citing papers authored by Marion Friedl

Since Specialization
Citations

This map shows the geographic impact of Marion Friedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Friedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Friedl more than expected).

Fields of papers citing papers by Marion Friedl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Friedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Friedl. The network helps show where Marion Friedl may publish in the future.

Co-authorship network of co-authors of Marion Friedl

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Friedl. A scholar is included among the top collaborators of Marion Friedl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Friedl. Marion Friedl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Xiao‐Qing, Lisa A. Brenner, Thomas B. Cook, et al.. (2018). Moderation of the relationship between Toxoplasma gondii seropositivity and trait impulsivity in younger men by the phenylalanine-tyrosine ratio. Psychiatry Research. 270. 992–1000. 10 indexed citations
2.
Konte, Bettina, Gregor Leicht, Ina Giegling, et al.. (2017). A genome-wide association study of early gamma-band response in a schizophrenia case–control sample. The World Journal of Biological Psychiatry. 19(8). 602–609. 4 indexed citations
3.
Balestri, Martina, Raffaella Calati, Alessandro Serretti, et al.. (2017). Maoa and Maob polymorphisms and personality traits in suicide attempters and healthy controls: a preliminary study. Psychiatry Research. 249. 212–217. 6 indexed citations
4.
Okusaga, Olaoluwa, Dietmar Fuchs, Gloria Reeves, et al.. (2016). Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies. Psychosomatic Medicine. 78(8). 931–939. 21 indexed citations
5.
Lowry, Christopher A., Thomas B. Cook, Lisa A. Brenner, et al.. (2016). Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine – tyrosine ratio of their associations with trait aggression. Pteridines. 27(3-4). 77–85. 6 indexed citations
6.
Okusaga, Olaoluwa, Dietmar Fuchs, Christopher A. Lowry, et al.. (2016). Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia. Frontiers in Public Health. 4. 182–182. 7 indexed citations
7.
Okusaga, Olaoluwa, Erica Duncan, Patricia Langenberg, et al.. (2015). Combined Toxoplasma gondii seropositivity and high blood kynurenine – Linked with nonfatal suicidal self-directed violence in patients with schizophrenia. Journal of Psychiatric Research. 72. 74–81. 29 indexed citations
8.
Cook, Thomas B., Lisa A. Brenner, C. Robert Cloninger, et al.. (2014). “Latent” infection with Toxoplasma gondii: Association with trait aggression and impulsivity in healthy adults. Journal of Psychiatric Research. 60. 87–94. 89 indexed citations
9.
Okusaga, Olaoluwa, Dietmar Fuchs, Ayesha Ashraf, et al.. (2014). Elevated Levels of Plasma Phenylalanine in Schizophrenia: A Guanosine Triphosphate Cyclohydrolase-1 Metabolic Pathway Abnormality?. PLoS ONE. 9(1). e85945–e85945. 25 indexed citations
10.
Okusaga, Olaoluwa, Robert G. Hamilton, Adem Can, et al.. (2014). Phadiatop Seropositivity in Schizophrenia Patients and Controls: A Preliminary Study. AIMS Public Health. 1(2). 43–50. 4 indexed citations
11.
Drago, Antonio, Ina Giegling, Martin Schäfer, et al.. (2014). Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment. Pharmacogenetics and Genomics. 24(6). 314–319. 24 indexed citations
12.
Reeves, Gloria, Søren Snitker, Patricia Langenberg, et al.. (2013). A Positive Association between T. gondii Seropositivity and Obesity. Frontiers in Public Health. 1. 73–73. 34 indexed citations
13.
Calati, Raffaella, Ina Giegling, Martina Balestri, et al.. (2013). Influence of differentially expressed genes from suicide post-mortem study on personality traits as endophenotypes on healthy subjects and suicide attempters. European Archives of Psychiatry and Clinical Neuroscience. 264(5). 423–432. 7 indexed citations
14.
Okusaga, Olaoluwa, Robert H. Yolken, Patricia Langenberg, et al.. (2013). Elevated gliadin antibody levels in individuals with schizophrenia. The World Journal of Biological Psychiatry. 14(7). 509–515. 33 indexed citations
15.
Hohenberg, Christian Clemm von, Marek Kubicki, Gregor Leicht, et al.. (2013). CNTNAP2 polymorphisms and structural brain connectivity: A diffusion-tensor imaging study. Journal of Psychiatric Research. 47(10). 1349–1356. 35 indexed citations
16.
Baldinger, P., Andreas Hahn, Markus Mitterhauser, et al.. (2013). Impact of COMT genotype on serotonin-1A receptor binding investigated with PET. Brain Structure and Function. 219(6). 2017–2028. 12 indexed citations
17.
Drago, Antonio, Ina Giegling, Martin Schäfer, et al.. (2012). AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment. European Neuropsychopharmacology. 23(8). 887–894. 22 indexed citations
18.
Antypa, Niki, Ina Giegling, Raffaella Calati, et al.. (2012). MAOA and MAOB polymorphisms and anger-related traits in suicidal participants and controls. European Archives of Psychiatry and Clinical Neuroscience. 263(5). 393–403. 30 indexed citations
19.
Nothdurfter, Caroline, Ina Giegling, Bettina Konte, et al.. (2012). Lack of association of the 5‐HT3A receptor with schizophrenia. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 159B(3). 310–315. 7 indexed citations
20.
Okusaga, Olaoluwa, Patricia Langenberg, Annette M. Hartmann, et al.. (2011). Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophrenia Research. 133(1-3). 150–155. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026